Pronabive will generate more than 20 million biologicals for animal health in Mexico

Published 2023년 3월 7일

Tridge summary

Pronabive, the National Producer of Veterinary Biologicals in Mexico, aims to produce 21.05 million doses of biologicals for the livestock sector in 2023, with a focus on Mexico and Central and South America. This is an increase from the 14.5 million units produced in 2022. Pronabive's product portfolio includes vaccines and diagnostic reagents for various animal diseases such as brucellosis, equine encephalitis, and bovine tuberculosis. These products are distributed through partnerships with state committees, organizations, and the Mexican veterinary pharmaceutical industry. The company's work is seen as crucial for supporting nations like Guatemala, Argentina, and Brazil in health matters, contributing to their security and enabling the continuation of livestock trade with more than 190 countries.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

From the National Producer of Veterinary Biologicals (Pronabive), they announced that this year they have the objective of generating 21.05 million doses of biologicals for the livestock sector, both in Mexico and in the Central and South American region. Igor Francisco Romero Sosa, director of Pronabive, highlighted that in 2022 the production of vaccines and diagnostic reagents against animal diseases amounted to 14.5 million units, which were marketed through contracts with state committees for the Promotion and Protection of Livestock, organizations members and with the Mexican veterinary pharmaceutical industry. Animal health for livestock, poultry and swine In total, the agency of the Ministry of Agriculture and Rural Development (Agriculture) has 28 medicines, including those focused on brucellosis, equine encephalitis, viral haemorrhagic disease of rabbits, Avian Influenza, bovine tuberculosis and rabies; in addition to vaccines for West Nile virus encephalitis, Newcastle ...
Source: Ganaderia

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.